(Q34474008)

2 August 2017

1 reference

title

Analysis of pharmacoeconomics of sedation and analgesia (English)

1 reference

2 August 2017

Wittbrodt ET

1

1 reference

2 August 2017

publication date

1 October 2001

1 reference

2 August 2017

published in

Critical Care Clinics

1 reference

2 August 2017

volume

17

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

1003-13, x

1 reference

Comparison of sedative recovery time after midazolam versus diazepam administration.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Propofol vs midazolam in short-, medium-, and long-term sedation of critically ill patients. A cost-benefit analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Comparative study of propofol versus midazolam in the sedation of critically ill patients: results of a prospective, randomized, multicenter trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

A clinician's guide to cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Sedation of critically ill patients during mechanical ventilation. A comparison of propofol and midazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

A cost analysis of alfentanil+propofol vs morphine+midazolam for the sedation of critically ill patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

A prospective evaluation of empiric versus protocol-based sedation and analgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Propofol or midazolam for sedation and early extubation following cardiac surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0749-0704%2805%2970191-3

7 January 2021

10.1016/S0749-0704(05)70191-3

Identifiers

DOI

1 reference

2 August 2017

1 reference